Compass Therapeutics Inc
(CMPX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2002 | 06-2002 | 03-2002 | 12-2001 | 09-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 980 | 4,940 | 3,610 | 2,580 | 1,190 |
| Depreciation Amortization | 420 | 1,760 | 1,290 | 820 | 430 |
| Other Working Capital | -1,280 | -1,180 | -1,520 | -1,690 | -850 |
| Other Operating Activity | 10 | -650 | 10 | 0 | -10 |
| Operating Cash Flow | $130 | $4,870 | $3,390 | $1,710 | $760 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -550 | -830 | -670 | -430 | -130 |
| Other Investing Activity | -20 | 20 | 10 | 10 | 10 |
| Investing Cash Flow | $-570 | $-810 | $-660 | $-420 | $-120 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 500 | -3,470 | -1,710 | 250 | 1,500 |
| Financing Cash Flow | $500 | $-3,470 | $-1,710 | $250 | $1,500 |
| Exchange Rate Effect | 30 | 740 | 290 | 260 | 40 |
| Beginning Cash Position | 2,080 | 760 | 760 | 760 | 760 |
| End Cash Position | 2,180 | 2,080 | 2,060 | 2,560 | 2,940 |
| Net Cash Flow | $90 | $1,320 | $1,300 | $1,800 | $2,180 |
| Free Cash Flow | |||||
| Operating Cash Flow | 130 | 4,870 | 3,390 | 1,710 | 760 |
| Free Cash Flow | 130 | 4,870 | 3,390 | 1,710 | 760 |